NISHA MUNJAPARA: Open Payments
NPI 1023416948 · STANFORD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$730 in 27 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $730
Food & beverage: $730
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 8 | $202 |
| Janssen Biotech, Inc. | 3 | $81 |
| Regeneron Healthcare Solutions, Inc. | 3 | $73 |
| Geron Corporation | 1 | $66 |
| BeOne Medicines USA, Inc. | 2 | $62 |
| Merck Sharp & Dohme LLC | 2 | $57 |
| Rigel Pharmaceuticals, Inc. | 2 | $44 |
| PharmaEssentia USA Corporation | 2 | $38 |
| Kite Pharma, Inc. | 1 | $31 |
| ABBVIE INC. | 1 | $30 |
Products named: INJECTAFER, Vanflyta, LYNOZYFIC, RYTELO, TALVEY, BRUKINSA, KEYTRUDA, TAVALISSE.
Industry payments across CA — which companies pay providers there.
